search legion

Head-to-head · HR software

Pave vs CompAnalyst

Pave offers free benchmark access; CompAnalyst has a 14-day trial. Neither publishes paid prices.

Pave

6.5/10
VS

CompAnalyst

6.0/10

We may earn a commission if you buy through links on this page. It never changes a score or a ranking. How we make money

Short answer

Most buyers should pick Pave.

Choose Pave if you want a free starting point for salary and equity benchmarks: Market Data Lite covers 1–200 employees and two locations, while paid prices and add-on costs are not published. Choose CompAnalyst if you want a quote-built compensation platform with a 14-day Market Data Max trial and data that combines job postings with benchmarks. Neither publishes standard pricing, and the published information does not establish which is easier to learn or offers stronger support.

01Side by side

PaveCompAnalyst
Starting priceFree Market Data Lite; paid prices not publishedQuote-based; 14-day Market Data Max trial
Free planYes: Market Data Lite, for 1–200 employeesNo; 14-day trial, no credit card required
Best forTeams wanting free salary and equity benchmarksOrganizations seeking tailored benchmarking and pay workflows
Core strengthBenchmarks, market pricing, planning, and rewardsReal-time market data, salary structures, and audit trails
Learning curveNot publishedNot published
Integrations/data9,000+ participating companies; 290+ job familiesJob-posting data combined with trusted benchmarks
Team/seat costsAdd-on prices unpublished; Lite caps at 200 employeesQuote scales by employee count and jobs; seat costs unpublished
SupportSupport terms not publishedSupport terms not published

Choose Pave if

  • Choose Pave if you want free salary and equity benchmarks.
  • Choose Pave if your team has 1–200 employees.
  • Choose Pave if you want compensation data plus rewards tools.

Choose CompAnalyst if

  • Choose CompAnalyst if you want a 14-day Market Data Max trial.
  • Choose CompAnalyst if you need pricing tailored to your organization.
  • Choose CompAnalyst if job-posting data matters to your benchmarking.

02Pricing compared

Pave has a free entry point, but not a published price for its broader platform. Market Data Lite costs nothing and covers 1–200 employees, 290+ job families, 9,000+ participating companies, and two locations: the U.S. plus one other. Market Data Pro, Agentic Market Intelligence, Agentic Workflows, and add-ons such as Compensation Planning have no published prices or billing terms.

CompAnalyst is quote-based, with pricing tailored to the organization and scaled by employee count and jobs managed. Its pricing information lists a 14-day Market Data Max trial with no credit card required, but no standard monthly or annual price. Add-on costs, seat costs, and overages are also unpublished. We can’t establish which platform costs less; ask both vendors for a quote covering your required modules and users.

03Features and depth

Pave combines compensation benchmarks with tools for pricing roles, planning merit cycles, and communicating pay. Its free Market Data Lite plan is limited to two locations; Market Data Pro adds coverage across 60+ countries and 90+ metros, unlimited global benchmarks and geo diffs, exports, and custom peer groups. Higher tiers add AI analysis, job architecture and pricing, data warehouse capabilities, and workflow automation. Compensation Planning, Team View, Total Rewards, and Visual Offer Letters are listed as add-ons, with prices not published.

CompAnalyst focuses on job benchmarking, salary structures, compensation analytics, planning, and decision audit trails. Its Max offering combines job-posting data with compensation benchmarks and adds AI-powered workflows. The published information does not specify geographic coverage or limits for CompAnalyst, so compare those details directly with Pave’s published plan limits. Pave’s stated data comes from 9,000+ participating companies; CompAnalyst’s value proposition emphasizes combining postings with benchmarks rather than a published contributor count.

04Ease of use and learning curve

The available information does not establish which product is easier to learn. Both cover more than looking up a salary: Pave spans benchmarking, pricing, planning, and employee-facing rewards, while CompAnalyst includes benchmarking, salary structures, analytics, and planning workflows. That breadth may mean more decisions about setup and scope, but the published sources do not document onboarding time or interface complexity.

CompAnalyst lists a 14-day Market Data Max trial with no credit card required, giving buyers a defined evaluation window. Pave lists free Market Data Lite, but the sources do not state whether it includes a guided trial or onboarding. Before choosing, ask each vendor to show the workflows your team will actually use and clarify implementation and training costs.

Questions people ask

Which is cheaper, Pave or CompAnalyst?

There is not enough published pricing to say. Pave’s Market Data Lite is free, but prices for its paid plans and add-ons are not published. CompAnalyst uses custom quotes, and its standard prices and add-on costs are also unpublished. Request quotes based on the same employee count and feature needs.

Does Pave have a free plan?

Yes. Pave’s Market Data Lite is listed as free and covers 1–200 employees, 290+ job families, 9,000+ participating companies, and two locations: the U.S. plus one. The published information does not say that its paid plans or add-ons are free.

Which platform has more global compensation data?

Pave publishes a specific global limit: Market Data Pro covers 60+ countries and 90+ metros, with unlimited global benchmarks and geo diffs. The published CompAnalyst information does not specify geographic coverage, so we can’t make a direct comparison without details from its sales team.

Does CompAnalyst offer a free trial?

CompAnalyst lists a 14-day Market Data Max trial that requires no credit card. The published information does not describe a free trial for Pave. Pave does list Market Data Lite as a free plan, which is a separate starting option rather than a stated trial.